Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 39 of 99

  1. FAVIR 200 MG FT

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  2. FB102

    Forteo

    Alopecia Areata

    phase 1 small molecule active

    1 trial

  3. FB102

    Forteo

    Vitiligo

    phase 1 small molecule active

    1 trial

  4. FGI-101-1A6

    United Therapeutics Europe Ltd

    Influenza

    phase 1 small molecule active

    1 trial

  5. FHD-286

    Foghorn Therapeutics

    Advanced Hematologic Malignancy

    phase 1 small molecule active

    1 trial

  6. FHD-286

    Foghorn Therapeutics

    Metastatic Uveal Melanoma

    phase 1 small molecule terminated

    1 trial

  7. FHD-609

    Foghorn Therapeutics

    Advanced Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

  8. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  9. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  10. FMT capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    phase 1 mab active

    1 trial

  11. FMX-101

    VYNE Therapeutics

    Healthy

    phase 1 small molecule completed

    3 trials

  12. FMX101

    VYNE Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  13. FMX101 vehicle

    VYNE Therapeutics

    Acne Vulgaris

    phase 1 small molecule completed

    1 trial

  14. FMX101, Minocycline 4% foam

    VYNE Therapeutics

    Acne

    phase 1 small molecule completed

    1 trial

  15. FP-1039

    Prime Medicine

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  16. FP01

    Avalo Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  17. FPA008

    Prime Medicine

    Healthy

    phase 1 small molecule terminated

    1 trial

  18. FPA144

    Prime Medicine

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  19. FPA150

    Prime Medicine

    Breast Cancer

    phase 1 mab terminated

    1 trial

  20. FPI-2505-001

    Lacuna Pharma Pty Ltd

    small cell lung cancer, non-smallcell lung cancer, colorectal cancer, breast cancer, Pancreatic cancer and gastric cancer

    phase 1 other active

    1 trial

  21. FPT155

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial

  22. FS120-19101

    Lacuna Pharma Pty Ltd

    Advanced Malignancies

    phase 1 other active

    1 trial

  23. FS222-19101

    Lacuna Pharma Pty Ltd

    Advanced Malignancies

    phase 1 other active

    1 trial

  24. FT-003

    The First People's Hospital of Lianyungang

    Neovascular Age-related Macular Degeneration

    phase 1 gene therapy active

    1 trial

  25. FT-003

    The First People's Hospital of Lianyungang

    Diabetic Macular Edema

    phase 1 gene therapy active

    1 trial

  26. FT500

    Zafatek

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  27. FT516

    Zafatek

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  28. FT516

    Zafatek

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  29. FT522

    Zafatek

    Relapsed/Refractory B-Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  30. FT536

    Zafatek

    Astrocytoma

    phase 1 mab active

    1 trial

  31. FT536

    Zafatek

    Non Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  32. FT538

    Zafatek

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  33. FT538

    Zafatek

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  34. FT576 (Allogenic CAR NK cells with BCMA expression)

    Zafatek

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  35. FT596

    Zafatek

    Diffuse Large B Cell Lymphoma

    phase 1 small molecule terminated

    1 trial

  36. FT596

    Zafatek

    Lymphoma, B-Cell

    phase 1 small molecule terminated

    1 trial

  37. FT819

    Zafatek

    Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)

    phase 1 small molecule active

    1 trial

  38. FT819

    Zafatek

    Lymphoma, B-Cell

    phase 1 small molecule active

    1 trial

  39. FT819 in B-cell Mediated Autoimmune Diseases

    Zafatek

    B-cell Mediated Autoimmune Diseases

    phase 1 other active

    1 trial

  40. FT825

    Zafatek

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  41. FT836

    Zafatek

    Non-Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  42. FTX-6058/placebo oral capsule(s)

    Fulcrum Therapeutics

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  43. FURMO-002

    ArriVent BioPharma

    Non-Small Cell Lung Cancer (NSCLC) harboring activating EGFR or HER2 kinase domain mutations

    phase 1 other active

    1 trial

  44. FVH1 - a DNA-based influenza vaccine

    INOVIO PHARMACEUTICALS, INC.

    Influenza, Human

    phase 1 mab completed

    1 trial

  45. FX201

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 1 mab active

    1 trial

  46. FX301

    Pacira Ireland Limited

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  47. FYB206-C1-01

    Formycon AG

    Melanoma: Adjuvant treatment of patients with Stage IIB, IIC, or III melanoma following complete resection

    phase 1 other active

    1 trial

  48. FYU-981

    Mochida Pharmaceutical Company,

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.